A poorly characterized protein, historically thought to be a chaperon or enzyme, may actually be a key player in prostate ...
Recognized in the Biotechnology category of the 2025 Top Innovations contest, small Cas12l nucleases are versatile, ...
In a world first, a bespoke gene-editing therapy benefited one child. Now researchers plan to launch a clinical trial of the approach ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback